Company / Shares Outstanding
Cytokinetics Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
120.1K
FY2025
5-year range
120.1K / 101.6M
FY2021-FY2025
Trend
-99.9%
vs FY2024
Sector context
#210 of 212
Health Care
What the data says
Among 212 Health Care companies, Cytokinetics is in the top 1% for shares outstanding. Improved from 94833975.00 to 120103.00 over the past 2 years.
Based on SEC 10-K filings.
120103.00 in FY2025 with a 5-year CAGR of -72.1%.
Improved from 94833975.00 to 120103.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -88.8%
- 5-Year CAGR
- -72.1%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 212This company 120.1K Sector average 306.7M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 99.9% year-over-year.
- Ranks #210 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 120.1K | -99.9% |
| FY2024 | 101.6M | +7.2% |
| FY2023 | 94.8M | +11.8% |
| FY2022 | 84.8M | +0.0% |
| FY2021 | 84.8M | +19.4% |
| FY2020 | 71.0M | +20.0% |
| FY2019 | 59.2M | +8.1% |
| FY2018 | 54.7M | +1.4% |
| FY2017 | 54.0M | +32.8% |
| FY2016 | 40.6M | +2.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026